FDA Inspection 1234264 — Combe Laboratories, Inc.

Combe Laboratories, Inc. — FEI 1450238

The FDA completed an inspection of Combe Laboratories, Inc. on Mar 28, 2024 in Rantoul, IL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI)
End Date
Mar 28, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Rantoul, IL (United States)